HN07P SMOKING CESSATION IN PATIENTS UNDERGOING TREATMENT FOR HEAD AND NECK CANCER
β Scribed by K. Rajpal; C. A. Mackinnon; S. T. Tan
- Book ID
- 108996501
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 62 KB
- Volume
- 79
- Category
- Article
- ISSN
- 1445-1433
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. Smoking withdrawal and relapse were characterized among newly diagnosed head and neck cancer patients participating in a physician-delivered smoking cessation intervention. Methods. Patients completed questionnaires at baseline, 1, 6, and 12 months following intervention delivery. Resu
Background. Alterations in serum levels of several glycoprotein constituents are reported to be useful for treatment monitoring of cancer patients. The purpose of this study was to determine efficacy of sialic acid and seromucoid fraction as treatment monitors for head and neck (H&N) cancer patients